| Genomic characterization of metastatic castration‐resistant prostate cancer patients undergoing PSMA radioligand therapy: A single‐center experience S Satapathy, CK Das, P Aggarwal, A Sood, AS Parihar, SK Singh, ... The Prostate 83 (2), 169-178, 2023 | 5 | 2023 |
| Increased PSMA Expression in 177Lu-PSMA-617 Scan in Metastatic Castrate-Resistant Prostate Cancer Patient Treated With PSMA Radioligand Therapy and Enzalutamide: A Potential … P Aggarwal, K Kaur, A Sood, K Periasamy, S Nagi, BR Mittal Clinical Nuclear Medicine 48 (5), 411-413, 2023 | 3 | 2023 |
| Excellent Response to Full-Dose 177Lu-PSMA-617 RLT in Metastatic Castration-Resistant Prostate Cancer With Transplant Kidney: A Step Ahead RA Mahdi, P Aggarwal, S Kumar, A Sood, D Paul, BR Mittal Clinical Nuclear Medicine 48 (10), e470-e471, 2023 | 2 | 2023 |
| Sunitinib in Tandem With 177Lu-DOTATATE Therapy in Advanced Pancreatic Neuroendocrine Tumor: A New Treatment Approach P Aggarwal, V Gunasekaran, A Sood, K Gupta, CK Das, BR Mittal Clinical Nuclear Medicine 49 (2), e85-e86, 2024 | 1 | 2024 |
| Potential role of 68Ga-PSMA PET/CT in metastatic renal cell cancer: A prospective study P Aggarwal, H Singh, CK Das, RS Mavuduru, N Kakkar, A Lal, U Gorsi, ... European Journal of Radiology 170, 111218, 2024 | 1 | 2024 |
| 177Lu-DOTATATE Salvage Therapy in Rapidly Progressing Neuroendocrine Tumor With Poor Performance Status P Aggarwal, A Kumar, A Sood, R Walia, SK Bhadada, BR Mittal Clinical Nuclear Medicine 49 (6), 561-563, 2024 | | 2024 |
| Early response assessment to targeted therapy in metastatic clear cell renal cancer using 68Ga-PSMA-11 PET/CT and comparison with CECT: a feasibility study P Aggarwal, H Singh, CK Das, RS Mavuduru, A Lal, N Kakkar, R Kumar, ... Clinical and Translational Imaging, 1-10, 2024 | | 2024 |
| Neoadjuvant Peptide Receptor Radionuclide Therapy in a Rare Case of Pediatric Primary Hepatic Gastrinoma S Mahato, P Aggarwal, C Thunga, A Sood, RP Kanojia, R Nada, SB Lal Clinical Nuclear Medicine 49 (4), e161-e163, 2024 | | 2024 |
| 68Ga-Pentixafor PET/CT for in-vivo mapping of CXCR4 receptors as potential radiotheranostic targets in soft tissue and bone sarcoma: preliminary results SR Jena, A Watts, P Aggarwal, V Bachhal, H Kaur, K Dhingra, H Singh, ... Nuclear Medicine Communications 45 (3), 229-235, 2024 | | 2024 |
| Estimation of absorbed dose to salivary glands in mCRPC patients undergoing 177 Lu-PSMA-617 radioligand therapy using quantitative SPECT-CT at single time point: a single … K Kaur, S Nagi, S Satapathy, P Aggarwal, A Sood, BR Mittal Nuclear Medicine Communications 45 (2), 115-120, 2024 | | 2024 |
| Incidentally Detected Gallbladder Carcinoma: Can F-18 FDG PET/CT Aid in Staging and Prognostication? VS Krishnaraju, R Kumar, BR Mittal, H Singh, P Aggarwal, H Singh, ... Nuclear Medicine and Molecular Imaging, 1-9, 2024 | | 2024 |
| PP047 Concomitant 177Lu-DOTATATE and low dose capecitabine versus 177Lu-DOTATATE alone in patients with advanced well-differentiated gastroenteropancreatic neuroendocrine … A Sood, P Aggarwal, S Satapathy, KR Chandekar, CK Das, A Kumar, ... ESMO Open 8 (1), 2023 | | 2023 |
| Molecular Imaging of Hepatobiliary Cancers K Subramanian, P Aggarwal, LT Hall, H Singh, AM Takalkar, BR Mittal Exon Publications, 121-137, 2023 | | 2023 |
| Hot Embolus Artifact Mimicking Disease Progression in Post-therapy 177Lu-DOTATATE Scan: Incremental Value of SPECT/CT P Aggarwal, A Anwariya, AJ Kavanal, A Sood, SR Jena, BR Mittal Nuclear Medicine and Molecular Imaging 57 (3), 159-161, 2023 | | 2023 |
| Early response assessment to tyrosine kinase inhibitors in metastatic clear cell cancer using 68Ga-PSMA-11 PET and CECT: A comparison study P Aggarwal, H Singh, C Das, R Mavuduru, A Lal, N Kakkar, R Kumar, ... Journal of Nuclear Medicine 64 (supplement 1), P1288-P1288, 2023 | | 2023 |
| Comparison of 68Ga-PSMA-11 with 18F-FDG PET/CT and correlation with tissue PSMA and CD31 expression using IHC in advanced non-small cell lung cancer A Sood, A Anwariya, P Aggarwal, S Satapathy, H Singh, A Bal, N Singh, ... Journal of Nuclear Medicine 64 (supplement 1), P645-P645, 2023 | | 2023 |
| Radioactive Iodine Uptake in Postoperative Seroma: A Cause for False Positivity P Aggarwal, RK Seenivasagam, A Sood, S Prashar, P Pathak, ... Journal of Nuclear Medicine Technology 51 (1), 68-69, 2023 | | 2023 |
| 68Ga-DOTANOC PET/CT in Adrenal Schwannoma P Aggarwal, H Singh, R Kumar, R Nada, GS Bora, R Walia Clinical Nuclear Medicine 48 (1), e22-e23, 2023 | | 2023 |
| False positive finding on whole-body iodine-131 scan secondary to contaminated face mask: an uncommon peril in current COVID pandemic A Anwariya, P Aggarwal, A Sood, N Tigapuram, S Prashar Asia Oceania Journal of Nuclear Medicine and Biology 11 (1), 82, 2023 | | 2023 |
| Bilateral Pelvic Kidney Masquerading as Horseshoe Kidney in Fanconi Anemia T Sindhu, VS Krishnaraju, A Sood, P Aggarwal, A Bhattacharya, D Bansal, ... Journal of Nuclear Medicine Technology 50 (4), 379-380, 2022 | | 2022 |
Harmandeep SinghPGIMERVerified email at pgimer.edu.in
